International Symposium on Trends in Radiopharmaceuticals (ISTR-2023)

Scientific Programme

• Production of diagnostic (Positron Emission Tomography; PET and Single Photon Emission Computed Tomography; SPECT), therapeutic and theranostic medical radioisotopes

• Production of radionuclide generators

• Production of diagnostic, therapeutic and theranostic radiopharmaceuticals

• Production and quality control of alpha emitter radiopharmaceuticals

• Research and development related to the production of medical radioisotopes and radiopharmaceuticals

• Quality control and quality assurance of medical radioisotopes and radiopharmaceuticals

• Preclinical evaluation of radiopharmaceuticals including data needed for approvals, case studies including animal/human compliance and statistics

• Dosimetry for new radiopharmaceuticals (both imaging and therapeutic agents)

• Good Manufacturing Practices (GMP) and other guidelines for production of medical radioisotopes and radiopharmaceuticals

• Design of radiopharmacy (industrial, hospital and centralized) facilities

• Regulatory aspects related to radiopharmaceuticals

• Accelerators for radioisotope production (choice, design etc.)

• Radiopharmacy Chapter in Pharmacopoeias

• Women in radiopharmaceutical sciences, trends, challenges, and future

• Education, including e-learning, certification and training methodologies for professionals involved in radiopharmaceutical sciences

• Introduction to the latest innovations in the radioisotopes and radiopharmaceutical industry